NCT04352036 Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
| NCT ID | NCT04352036 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Acute Hidrosadenitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 465 participants |
| Start Date | 2022-01-04 |
| Primary Completion | 2030-02-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 465 participants in total. It began in 2022-01-04 with a primary completion date of 2030-02-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our primary objective with this cohort will be to define the different phenotypes of acute hidrosadenitis, the characterization of which is essential to define suitable therapeutic approaches. Indeed, our recent data allow us to note that there would be different phenotypes of acute hidrosadenitis and therefore different pathologies inducing different follow-ups and care.
Eligibility Criteria
Inclusion Criteria: * Patient diagnosed with acute hidrosadenitis by a dermatologist * Patient agreeing to be part of the study Exclusion Criteria: * Major under guardianship * Protected persons
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04352036 clinical trial?
This trial is open to participants of all sexes, studying Acute Hidrosadenitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04352036 currently recruiting?
Yes, NCT04352036 is actively recruiting participants. Contact the research team at brigitte.dreno@wanadoo.fr for enrollment information.
Where is the NCT04352036 trial being conducted?
This trial is being conducted at Angers, France, Brest, France, La Roche-sur-Yon, France, La Rochelle, France and 9 additional locations.
Who is sponsoring the NCT04352036 clinical trial?
NCT04352036 is sponsored by Nantes University Hospital. The trial plans to enroll 465 participants.